1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
The Hanover Insurance Group said CEO John C. Roche will retire as president, CEO and board member effective December 31, 2026. Chief Operating Officer Richard W. Lavey has been named CEO-elect and is expected to succeed Roche as CEO at that time, with a board seat from January 1, 2027. The filing reports no financial results, but it changes the company's top executive role.
John C. Roche, 62, retires as president, CEO and board member effective December 31, 2026, and stays as an advisor through January 8, 2027.
Richard W. Lavey, 59, has been Executive Vice President and Chief Operating Officer since March 2025 and is named CEO-elect.
The Board intends to elect Lavey to the Board effective January 1, 2027.
The company's earnings call is scheduled for July 29, 2026, and its investor day for September 17, 2026.
American Airlines Group elected John W. Dietrich to its Board of Directors on July 15, 2026, and he will serve on the Audit and Finance Committees. Dietrich most recently was Executive Vice President and CFO of FedEx from 2023 to 2026, and previously spent more than two decades at Atlas Air Worldwide. The filing describes a board addition with finance and governance experience, and it reports no financial results or changes to company guidance.
Dietrich was elected to the board on July 15, 2026, and will serve on the Audit Committee and Finance Committee.
He was Executive Vice President and CFO of FedEx Corporation from 2023 to 2026.
He spent more than two decades at Atlas Air Worldwide, including as President and CEO.
He will receive director compensation on the same basis as other non-employee directors.
The Hartford Insurance Group named Randy Larsen, former CEO of AssuredPartners, as a director effective September 1, 2026, and placed him on the Finance, Investment and Risk Management Committee and the Nominating and Corporate Governance Committee. The change adds a director with insurance brokerage leadership experience and carries modest director pay, so it is a routine board addition rather than a change in company operations or financial results.
Randy Larsen's board service begins September 1, 2026, and he joins the Finance, Investment and Risk Management Committee and the Nominating and Corporate Governance Committee.
Larsen was CEO of AssuredPartners from 2023 until its acquisition by Gallagher in 2025, after 13 years with the firm.
For the remainder of the 2026-2027 board service year, he will receive a pro rata cash retainer of $82,700 and restricted stock units valued at $136,600.
The board determined that Larsen meets New York Stock Exchange independence requirements.
RxSight's board appointed Aziz Mottiwala as President and Chief Executive Officer on July 13, 2026, effective July 20, 2026, replacing Ron Kurtz, M.D., who has led the company since 2016. Kurtz moves to Chief Medical Officer and resigns from the board, and Mottiwala joins the board in his place. The company said it is not updating its previously communicated financial guidance.
Mottiwala, 48, was Chief Commercial Officer of Tarsus Pharmaceuticals from August 2020 to July 2026.
Mottiwala's pay includes a $750,000 base salary, a 2026 cash bonus of $337,500, and equity awards with a grant-date value of $14,000,000.
Kurtz keeps a $740,000 base salary and can earn retention bonuses of $370,000 on each of four dates from January 1, 2027 through July 1, 2028, if he remains employed.
The company is not updating its previously communicated financial guidance in connection with the announcement.
RLI Corp.'s Board appointed James H. Bradshaw as a director effective July 15, 2026, and named him to the Audit and Finance & Risk Committees. The Board determined he is independent under New York Stock Exchange rules, and he will stand for election at the next annual shareholders' meeting. The filing describes this as a board addition and reports no financial results.
James H. Bradshaw appointed to the Board effective July 15, 2026
Board determined Mr. Bradshaw is independent under NYSE rules
Appointed to the Audit and Finance & Risk Committees; term expires at the May 2027 shareholders' meeting
Bradshaw is Chairman of Gallagher Re North America, a role he assumed in 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.